- Home
- PERI vs ALDX Comparison
PERI vs ALDX Comparison
Compare PERI & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERI
- ALDX
- Stock Information
- Founded
- PERI 1999
- ALDX 2004
- Country
- PERI Israel
- ALDX United States
- Employees
- PERI N/A
- ALDX N/A
- Industry
- PERI EDP Services
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- PERI Technology
- ALDX Health Care
- Exchange
- PERI Nasdaq
- ALDX Nasdaq
- Market Cap
- PERI 412.5M
- ALDX 342.3M
- IPO Year
- PERI 2006
- ALDX 2014
- Fundamental
- Price
- PERI $9.22
- ALDX $5.09
- Analyst Decision
- PERI Buy
- ALDX Strong Buy
- Analyst Count
- PERI 4
- ALDX 2
- Target Price
- PERI $11.83
- ALDX $9.50
- AVG Volume (30 Days)
- PERI 254.1K
- ALDX 776.7K
- Earning Date
- PERI 11-05-2025
- ALDX 11-06-2025
- Dividend Yield
- PERI N/A
- ALDX N/A
- EPS Growth
- PERI N/A
- ALDX N/A
- EPS
- PERI N/A
- ALDX N/A
- Revenue
- PERI $424,098,000.00
- ALDX N/A
- Revenue This Year
- PERI N/A
- ALDX N/A
- Revenue Next Year
- PERI $11.45
- ALDX $63.48
- P/E Ratio
- PERI N/A
- ALDX N/A
- Revenue Growth
- PERI N/A
- ALDX N/A
- 52 Week Low
- PERI $7.00
- ALDX $1.14
- 52 Week High
- PERI $11.79
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- PERI 44.25
- ALDX 37.78
- Support Level
- PERI $9.06
- ALDX $5.48
- Resistance Level
- PERI $9.44
- ALDX $5.88
- Average True Range (ATR)
- PERI 0.21
- ALDX 0.29
- MACD
- PERI 0.06
- ALDX -0.10
- Stochastic Oscillator
- PERI 49.23
- ALDX 10.63
About PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.